RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVAX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Novavax stock upgraded to Buy Candidate.
(Updated on Apr 30, 2024)

Buy candidate since Apr 30, 2024 PDF

The Novavax stock price gained 0.93% on the last trading day (Tuesday, 30th Apr 2024), rising from $4.29 to $4.33. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.41% from a day low at $4.25 to a day high of $4.48. The price has risen in 6 of the last 10 days and is up by 8.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 337 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $18.11 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.34% during the next 3 months and, with a 90% probability hold a price between $3.78 and $5.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVAX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 11.31%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Novavax stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.49. On a fall, the stock will find some support from the short-term average at $4.15. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Novavax stock

Novavax finds support from accumulated volume at $4.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.230 between high and low, or 5.41%. For the last week, the stock has had daily average volatility of 5.03%.

Our recommended stop-loss: $4.16 (-3.94%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (NVAX) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Novavax Inc to open at $4.35, and during the day (based on 14 day Average True Range), to move between $4.09 and $4.57, which gives a possible trading interval of +/-$0.244 (+/-5.63%) up or down from last closing price. If Novavax Inc takes out the full calculated possible swing range there will be an estimated 11.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.30 (0.69%) than the resistance at $4.41 (1.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Novavax Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.136 Buy Candidate Upgraded

Predicted Opening Price for Novavax Inc of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$4.35 ( 0.539%) $4.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.58 5.85 %
R2 4.50 3.82 %
R1 4.44 2.57 %
Current price: 4.33
Support S1 4.27 -1.49 %
S2 4.21 -2.74 %
S3 4.12 -4.77 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.29 22.17 %
R2 4.88 12.70 %
R1 4.41 1.85 %
Current price 4.33
Support S1 4.30 -0.693%
S2 4.15 -4.16%
S3 3.93 -9.24%

FAQ

What is the symbol for Novavax Stock and on which exchange is it traded?
The symbol for Novavax is NVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Novavax Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Novavax Stock?
Novavax Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novavax Stock.

What's the current price of Novavax Stock?
As of the end of day on the Apr 30, 2024, the price of an Novavax (NVAX) share was $4.33.

What is the 52-week high and low for Novavax Stock?
The 52-week high for Novavax Stock is $11.36 and the 52-week low is $3.53.

What is the market capitalization of Novavax Stock?
As of the Apr 30, 2024, the market capitalization of Novavax is 600.398M.

When is the next earnings date for Novavax?
The upcoming earnings date for Novavax is May 14, 2024.
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT